A call for transparent reporting to optimize the predictive value of preclinical research
Top Cited Papers
Open Access
- 10 October 2012
- journal article
- research article
- Published by Springer Nature in Nature
- Vol. 490 (7419) , 187-191
- https://doi.org/10.1038/nature11556
Abstract
Deficiencies in methods reporting in animal experimentation lead to difficulties in reproducing experiments; the authors propose a set of reporting standards to improve scientific communication and study design. Animal studies have contributed immensely to our understanding of diseases and assist the development of new therapies, but inadequate experimental reporting can sometimes render such studies difficult to reproduce and to translate into the clinic. This year, a US National Institute of Neurological Disorders and Stroke workshop addressed this issue, and its conclusions are discussed in a Perspective piece in this issue of Nature. The main workshop recommendation is that at a minimum, studies should report on randomization, blinding, sample-size estimation and how the data were handled. The US National Institute of Neurological Disorders and Stroke convened major stakeholders in June 2012 to discuss how to improve the methodological reporting of animal studies in grant applications and publications. The main workshop recommendation is that at a minimum studies should report on sample-size estimation, whether and how animals were randomized, whether investigators were blind to the treatment, and the handling of data. We recognize that achieving a meaningful improvement in the quality of reporting will require a concerted effort by investigators, reviewers, funding agencies and journal editors. Requiring better reporting of animal studies will raise awareness of the importance of rigorous study design to accelerate scientific progress.Keywords
This publication has 66 references indexed in Scilit:
- Raise standards for preclinical cancer researchNature, 2012
- Factors Affecting the Apparent Efficacy and Safety of Tissue Plasminogen Activator in Thrombotic Occlusion Models of Stroke: Systematic Review and Meta-AnalysisJournal of Cerebral Blood Flow & Metabolism, 2010
- Pharmacokinetic/ Pharmacodynamic‐Driven Drug DevelopmentMount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine, 2010
- The problem of pseudoreplication in neuroscientific studies: is it affecting your analysis?BMC Neuroscience, 2010
- A Systematic Review and Meta-Analysis of Erythropoietin in Experimental StrokeJournal of Cerebral Blood Flow & Metabolism, 2009
- Update of the Stroke Therapy Academic Industry Roundtable Preclinical RecommendationsStroke, 2009
- Helping editors, peer reviewers and authors improve the clarity, completeness and transparency of reporting health researchBMC Medicine, 2008
- Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological studyBMJ, 2008
- Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trialsJAMA, 1995
- The file drawer problem and tolerance for null results.Psychological Bulletin, 1979